STOCK TITAN

ParkerVision permits resale of up to 18.0M shares

ParkerVision receives no proceeds from selling-stockholder resales, though cash exercise of the consulting warrant could generate up to $180,000 gross.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
424B3

Rhea-AI Filing Summary

ParkerVision, Inc.’s prospectus permits selling stockholders to resell up to 18,014,164 shares of common stock. This includes up to 5,457,583 shares issuable upon conversion of Tranche 1 Notes at a fixed $0.10 per-share conversion price; up to 10,131,581 shares issuable upon conversion of Tranche 2 Notes at a fixed $0.08 per-share conversion price; 625,000 shares issued for consulting services; and up to 1,800,000 shares issuable upon exercise of a five-year warrant at $0.10 per share, subject to adjustment. ParkerVision receives no proceeds from stockholder resales; if the warrant is exercised for cash, it may receive up to $180,000 in gross proceeds for general working capital and corporate purposes. On October 23, 2026, the board expanded from four to five members and appointed William G. Walters as a class II director.

Common stock permitted for resale Up to 18,014,164 shares Selling stockholders under the prospectus
Tranche 1 conversion shares Up to 5,457,583 shares Shares issuable upon conversion of Tranche 1 Notes
Tranche 1 fixed conversion price $0.10 per share Conversion of Tranche 1 Notes
Tranche 2 conversion shares Up to 10,131,581 shares Shares issuable upon conversion of Tranche 2 Notes
Tranche 2 fixed conversion price $0.08 per share Conversion of Tranche 2 Notes
Park Consulting Warrant shares Up to 1,800,000 shares Shares issuable upon exercise of the five-year warrant
Park Consulting Warrant exercise price $0.10 per share Subject to adjustment
Potential gross warrant proceeds Up to $180,000 If the Park Consulting Warrant is exercised for cash
convertible promissory notes financial
"shares issuable upon conversion of ... convertible promissory notes"
A convertible promissory note is a loan a company takes that can later be turned into shares instead of being paid back in cash; think of lending money now in exchange for a voucher that can become ownership later. Investors care because it mixes credit risk and potential ownership upside—it can protect lenders if a company struggles while also diluting existing shareholders when converted, affecting future share value and investor returns.
fixed conversion price financial
"which have a fixed conversion price"
Park Consulting Warrant financial
"exercise of a five-year warrant"
gross proceeds financial
"up to an aggregate of $180,000 in gross proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.
Offering Type secondary
Securities Offered Common stock for resale by selling stockholders
Offering Amount Up to 18,014,164 shares
Use of Proceeds ParkerVision receives no proceeds from selling-stockholder resales. If the Park Consulting Warrant is exercised for cash, ParkerVision may receive up to $180,000 in gross proceeds, which it expects to use for general working capital and corporate purposes.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PRKR shares may selling stockholders resell?

The prospectus permits selling stockholders to resell up to 18,014,164 shares of ParkerVision common stock. The amount includes shares issuable upon conversion of notes, shares issued for consulting services, and shares issuable upon exercise of a warrant.

Does ParkerVision receive proceeds from PRKR stock resales?

ParkerVision receives no proceeds from selling-stockholder sales. If the Park Consulting Warrant is exercised for cash, ParkerVision may receive up to $180,000 in gross proceeds, which it expects to use for general working capital and corporate purposes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Filed pursuant to Rule 424(b)(3)

Registration No. 333-233390

 

PROSPECTUS SUPPLEMENT No. 85

(to Prospectus dated September 11, 2019)

 

PARKERVISION, INC.

18,014,164 Shares of Common Stock

 

This Prospectus Supplement relates to the prospectus dated September 11, 2019, as amended and supplemented from time to time (the “Prospectus”) which permits the resale by the selling stockholders listed in the Prospectus of up to 18,014,164 shares of our common stock, par value $0.01 per share (“Common Stock”) consisting of (i) up to 5,457,583 shares of Common Stock issuable upon conversion of, and for the payment of interest from time to time at our option, for convertible promissory notes dated June 7, 2019 through July 15, 2019 which have a fixed conversion price of $0.10 per share (the “Tranche 1 Notes”), (ii) up to 10,131,581 shares of Common Stock issuable upon conversion of, and for the payment of interest from time to time at our option, for convertible promissory notes dated July 18, 2019 which have a fixed conversion price of $0.08 per share (the “Tranche 2 Notes”), (iii) up to 625,000 shares of Common Stock issued as payment for services in conjunction with a consulting agreement dated June 7, 2019 (the “Fisher Consulting Agreement”) and (iv) up to 1,800,000 shares of Common Stock issuable upon exercise of a five-year warrant with an exercise price of $0.10 per share, subject to adjustment and issued as payment for services in conjunction with a consulting agreement dated July 22, 2019 (the “Park Consulting Warrant”).

 

We will not receive proceeds from the sale of the shares of Common Stock by the selling stockholders. To the extent the Park Consulting Warrant is exercised for cash, we will receive up to an aggregate of $180,000 in gross proceeds. We expect to use proceeds received from the exercise of the Park Consulting Warrant, if any, for general working capital and corporate purposes.

 

This Prospectus Supplement is being filed to update and supplement the information previously included in the Prospectus with the information contained in our Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on October 29, 2026.  Accordingly, we have attached the 8-K to this prospectus supplement.  You should read this prospectus supplement together with the prospectus, which is to be delivered with this prospectus supplement.

 

Any statement contained in the Prospectus shall be deemed to be modified or superseded to the extent that information in this Prospectus Supplement modifies or supersedes such statement.  Any statement that is modified or superseded shall not be deemed to constitute a part of the Prospectus except as modified or superseded by this Prospectus Supplement.

 

This Prospectus Supplement should be read in conjunction with, and may not be delivered or utilized without, the Prospectus.

 

Our Common Stock is listed on the OTCQB Venture Capital Market under the ticker symbol “PRKR.” 

 

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 5 of this prospectus for a discussion of information that should be considered in connection with an investment in our securities.

 

Neither the SEC nor any such authority has approved or disapproved these securities or determined whether this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

The date of this Prospectus Supplement is October 29, 2026.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

______________

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): October 23, 2026

 

PARKERVISION, INC.

(Exact Name of Registrant as Specified in Charter)

     

Florida

000-22904

59-2971472

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

   

4446-1A Hendricks Avenue Suite 354, Jacksonville, Florida

32207

(Address of Principal Executive Offices)

(Zip Code)

 

(904) 732-6100

(Registrant’s Telephone Number, Including Area Code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol

Name of Each Exchange on Which Registered

None

 

 

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter.

 

Emerging growth company   ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

 

 

 

 

Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On October 23, 2026, the Board of Directors (the “Board”) of ParkerVision, Inc. (the "Company"), expanded the size of the Board from four to five members, adding a class II director vacancy.

 

The Board unanimously appointed William G. Walters to fill the director vacancy created by the Board expansion.

 

Mr. Walters, age 89, is retired from an investment banking career where he focused on micro and small cap companies.  He received a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania and a certificate from Harvard Business School's Owner/President Management (OPM) program.   

 

There are no arrangements or understandings between Mr. Walters and any other persons pursuant to which he was selected as a director.  There are no transactions involving Mr. Walters requiring disclosure under Item 404(a) of Regulation S-K.

 

Mr. Walters will receive the Company's standard non-employee director compensation arrangements.  The Company entered into its standard indemnification agreement with Mr. Walters.

 

The Company issued a press release announcing the appointment of Mr. Walters, a copy of which is furnished herewith as Exhibit 99.1.

 

 

 Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit

Description

99.1 Press Release dated October 29, 2026
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     

Dated: October 29, 2026

   
   

PARKERVISION, INC.

     
   

By /s/ Cynthia French

   

Cynthia French

   

Chief Financial Officer

 

 

Keep reading